These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 33167048)

  • 1. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
    Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
    Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nanoparticles for glioblastoma treatment: a new approach.
    Játiva P; Ceña V
    Nanomedicine (Lond); 2017 Oct; 12(20):2533-2554. PubMed ID: 28952878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
    Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
    Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.
    Baumann BC; Kao GD; Mahmud A; Harada T; Swift J; Chapman C; Xu X; Discher DE; Dorsey JF
    Oncotarget; 2013 Jan; 4(1):64-79. PubMed ID: 23296073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice.
    Qin H; Jiang Y; Zhang J; Deng C; Zhong Z
    Mol Pharm; 2019 Aug; 16(8):3711-3719. PubMed ID: 31299161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound.
    Yang Q; Zhou Y; Chen J; Huang N; Wang Z; Cheng Y
    Int J Nanomedicine; 2021; 16():185-199. PubMed ID: 33447034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
    Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
    Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma multiforme: a glance at advanced therapies based on nanotechnology.
    Rezaei V; Rabiee A; Khademi F
    J Chemother; 2020 May; 32(3):107-117. PubMed ID: 31984871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
    Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
    Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
    Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
    Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
    Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
    Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
    Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
    Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
    ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier.
    Wadhwa K; Chauhan P; Kumar S; Pahwa R; Verma R; Goyal R; Singh G; Sharma A; Rao N; Kaushik D
    Oncol Res; 2024; 32(5):877-897. PubMed ID: 38686045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.